![]() | |
Company type | 501(c)(3) Nonprofit Organization |
---|---|
Founded | in 2010 in New York City, New York, U.S. |
Founder |
|
Area served | North America |
Website | thejdca |
The Juvenile Diabetes Cure Alliance (JDCA) is a registered 501(c)(3) non-profit organization dedicated to developing a Practical Cure for type 1 diabetes. The organization advocates for increasing type 1 diabetes cure research and publishes reports on a variety of related topics, including research progress, fundraising utilization, and donor priorities. Established in 2010, the organization’s home office is in New York City and it focuses primarily on activity within the United States.
Activities include research, publishing, and advocating for T1D donors. All activities serve the nonprofit's ultimate purpose of bringing about what the organization calls a "Practical Cure" for type 1 diabetes. [1]
The organization defines a Practical Cure as any solution that gives people living with the disease the chance to live a normal, unrestricted life. The clinical requirements of a Practical Cure are defined by those living with T1D who understand the daily burden. Practical Cure requirements include testing blood sugars once a week or less, eating an unrestricted diet, a greatly reduced and simple regimen of medication, sleeping worry-free, experiencing minimal to no diabetes side effects, and experiencing fast recovery from surgeries. [2]
The JDCA was founded in 2010 by Brian Kelly, former Chairman of the Board of Activision Blizzard, after his son was diagnosed with type 1 diabetes at the age of two. Kelly founded the organization to accelerate a cure for type 1 diabetes within his son’s lifetime.
At the time of its founding, the JDCA adopted a business, results-focused perspective in an effort to hold major diabetes fundraising nonprofit organizations accountable for the absence of measurable progress tracking and a lack of transparency to the donor public. [3] One key theme maintained as the organization has evolved is that donor priorities and the utilization of funds by major fundraisers should be aligned. [4]
As of 2024, the JDCA has published over 500 reports on topics related to finding a cure for type 1 diabetes. These reports include updates to existing human clinical trials with the potential to become Practical Cures, financial analysis of the top nonprofit organizations, breaking news in T1D research, and others.
Between 30 and 40 reports are published per year on the Juvenile Diabetes Cure Alliance website and sent via email. All reports are free to the public to increase awareness and access to information regarding current developments in the T1D research ecosystem. There are four main types of reports: Type 1 diabetes human trials research, utilization of funds by large diabetes nonprofits and public sources, donor sentiment, and an annual State of the Cure for Type 1 Diabetes publication.
The JDCA tracks and categorizes type 1 diabetes potential Practical Cure research projects that are in human trials or about to start human trials. The list of projects is updated twice a year. While most projects have remained constant, some have been removed over time for insufficient test results and new ones have been added. [5]
The State of the Cure for Type 1 Diabetes (SOTC) provides an annual overview of progress toward a T1D cure throughout the year. [6] SOTC reflects on the challenges, advancements, and steps needed to move forward with finding a Practical Cure.
The organization evaluates the publicly available financial documents of major diabetes charities and publishes reports on how funds are utilized. [7] Topics covered include research grant allocation, research funding priorities, CEO compensation, and analyzing cure-based marketing versus cure-based funding. The purpose is to foster transparency, bring attention to discrepancies in research funding, and provide recommendations to larger, influential nonprofits to improve donor loyalty and expedite research progress. Breakthrough T1D and the American Diabetes Association are the common focus of this reporting.
The organization also believes that nonprofit executive pay should be primarily incentive-based; tied to both organizational advancements and tangible progress toward a T1D cure and treatment. [8] The JDCA also advocates for a donor Say on Pay model, in which donors would have a say in executive compensation, promoting accountability to nonprofit employees.
At the highest-performing for-profit companies, top executives’ annual compensation is often directly correlated to performance. The better the company does, the more executives are rewarded. This form of incentive creates a powerful professional and personal zeal to drive the company toward palpable results that benefit stakeholders and shareholders alike. This business model does not usually carry over to nonprofit organizations. The JDCA believes this is a missed opportunity to drive passion, accentuate focus, and improve overall performance toward achieving organizational goals.
Based on survey results, the JDCA publishes multiple annual reports that detail the sentiments of the T1D community, specifically regarding priorities and values. A consistent finding is that the number one priority of the T1D donor community is developing a cure for type 1 diabetes. According to annual community surveys, 97% of T1D donors say that the number one reason they donate is to fund cure research. [8]
The JDCA advocates for a significant increase in spending on cure research for type 1 diabetes through annual petitions. [9] Its activities have fostered some discussion within the diabetes community. [10] The 2023 9th Annual More for a T1D Cure petition to increase cure funding acquired 388,000 signatures. [11]
The JDCA also provides services for donors who want to legally stipulate how their gifts will be used. [12] [13]
The JDCA’s approach has been controversial for its focus on outcomes and expediency rather than traditional methods of deciding what projects to fund. [14]
Critics of the JDCA have stated that the definition of a cure can vary depending on who you ask. Others argue that a cure by 2035 is unobtainable and that improved diabetes treatments are a more valid outlet for funding than the JDCA acknowledges. [15]
A nonprofit organization (NPO), also known as a nonbusiness entity, nonprofit institution, or simply a nonprofit, is a legal entity organized and operated for a collective, public or social benefit, as opposed to an entity that operates as a business aiming to generate a profit for its owners. A nonprofit organization is subject to the non-distribution constraint: any revenues that exceed expenses must be committed to the organization's purpose, not taken by private parties. Depending on the local laws, charities are regularly organized as non-profits. A host of organizations may be nonprofit, including some political organizations, schools, hospitals, business associations, churches, foundations, social clubs, and consumer cooperatives. Nonprofit entities may seek approval from governments to be tax-exempt, and some may also qualify to receive tax-deductible contributions, but an entity may incorporate as a nonprofit entity without having tax-exempt status.
ChildFund, also known an ChildFund International, and formerly known as Christian Children's Fund, is a child-focused international development organization that provides assistance to children facing poverty and other challenges in 24 countries, including the United States. ChildFund's headquarters are located in Richmond, Virginia, United States.
Fundraising or fund-raising is the process of seeking and gathering voluntary financial contributions by engaging individuals, businesses, charitable foundations, or governmental agencies. Although fundraising typically refers to efforts to gather money for non-profit organizations, it is sometimes used to refer to the identification and solicitation of investors or other sources of capital for for-profit enterprises.
Breakthrough T1D is a type 1 diabetes (T1D) research and advocacy organization.
The American Diabetes Association (ADA) is a United States-based nonprofit that seeks to educate the public about diabetes and to help those affected by it through funding research to manage, cure and prevent diabetes, including type 1 diabetes, type 2 diabetes, gestational diabetes, and pre-diabetes. It is a network of 565,000 volunteers which includes 20,000 healthcare professionals and administration staff members.
The International Food Policy Research Institute (IFPRI) is an international research center focused on agriculture and food systems that provides research-based policy solutions to reduce poverty and end hunger and malnutrition throughout low- and middle-income countries in environmentally sustainable ways. For nearly 50 years, IFPRI has worked with policymakers, academics, nongovernmental organizations, the private sector, development practitioners, and others to carry out research, capacity strengthening, and policy communications on food systems, economic development, and poverty reduction.
Type 1 diabetes (T1D), formerly known as juvenile diabetes, is an autoimmune disease that occurs when pancreatic cells are destroyed by the body's immune system. In healthy persons, beta cells produce insulin. Insulin is a hormone required by the body to store and convert blood sugar into energy. T1D results in high blood sugar levels in the body prior to treatment. Common symptoms include frequent urination, increased thirst, increased hunger, weight loss, and other complications. Additional symptoms may include blurry vision, tiredness, and slow wound healing. While some cases take longer, symptoms usually appear within weeks or a few months.
Proposition 71 of 2004 is a law enacted by California voters to support stem cell research in the state. It was proposed by means of the initiative process and approved in the 2004 state elections on November 2. The Act amended both the Constitution of California and the Health and Safety Code.
Slowly evolving immune-mediated diabetes, or latent autoimmune diabetes in adults (LADA), is a form of diabetes that exhibits clinical features similar to both type 1 diabetes (T1D) and type 2 diabetes (T2D), and is sometimes referred to as type 1.5 diabetes. It is an autoimmune form of diabetes, similar to T1D, but patients with LADA often show insulin resistance, similar to T2D, and share some risk factors for the disease with T2D. Studies have shown that LADA patients have certain types of antibodies against the insulin-producing cells, and that these cells stop producing insulin more slowly than in T1D patients. Since many people develop the disease later in life, it is often misdiagnosed as type 2 diabetes.
The Center on Budget and Policy Priorities (CBPP) is a progressive American think tank that analyzes the impact of federal and state government budget policies. A 501(c)(3) nonprofit organization, the Center's stated mission is to "conduct research and analysis to help shape public debates over proposed budget and tax policies and to help ensure that policymakers consider the needs of low-income families and individuals in these debates."
The Alliance for Aging Research is a non-profit organization based in Washington, D.C., that promotes medical research to improve the human experience of aging. Founded in 1986 by Daniel Perry, the Alliance also advocates and implements health education for consumers and health professionals.
Diabetes Management Software refers to software tools that run on personal computers and personal digital assistants to help persons with Type 1 and Type 2 diabetes manage the data associated with:
Crossref is a nonprofit open digital infrastructure organization for the global scholarly research community. It is the largest digital object identifier (DOI) Registration Agency of the International DOI Foundation. It has 19,000 members from 150 countries representing publishers, libraries, research institutions, and funders and was launched in early 2000 as a cooperative effort among publishers to enable persistent cross-platform citation linking in online academic journals. As of July 2023, Crossref identifies and connects 150 million records of metadata about research objects made openly available for reuse without restriction. They facilitate an average of 1.1 billion DOI resolutions every month, and they see 1 billion queries of the metadata every month.
The Environmental Determinants of Diabetes in the Young is a longitudinal study examining the environmental causes of Type 1 diabetes (T1D), formerly known as juvenile diabetes. The study follows children at high genetic risk for T1D from birth to 15 years of age.
The Arthritis Foundation is a nonprofit organization addressing the needs of people living with arthritis in the United States.
The Coral Reef Alliance (CORAL) is an environmental non-profit, 501(c)(3) non-governmental organization based in Oakland, California that is dedicated to coral reef conservation. The organization was founded in 1994 by Stephen Colwell.
Candid is an information service specializing in reporting on U.S. nonprofit companies. In 2016, its database provided information on 2.5 million organizations. It is the product of the February 2019 merger of GuideStar with Foundation Center.
The Redstone Acceleration & Innovation Network (TRAIN) is an organization launched by FasterCures in 2004 established to create opportunities for medical research organizations to discuss and overcome research challenges that cut across all diseases. TRAIN brings together nonprofit disease research organizations to share information, as well as promote collaboration and innovation in disease research. Headed by FasterCures, TRAIN asserts that collaboration is crucial for efficient biomedical advancement. Participating researchers discuss successes, failures, and best practices that provide lessons learned and valuable ideas that could be scaled up to amplify productivity.
Sandler Foundation is a charitable foundation formed in 1991 with support from Herbert Sandler and Marion Sandler, co-CEOs of Golden West Financial Corporation and World Savings Bank. In 2006, the Sandlers made a contribution of $1.3 billion to the foundation, which was the second largest American charitable contribution of 2006. Sandler Foundation is a spend-down foundation as the Sandlers have signed The Giving Pledge. The Sandlers founded the nonprofit investigative news organization ProPublica.
Mark Atkinson is an American medical researcher best known for his contributions to research seeking to predict, prevent, and cure type 1 diabetes. He is the author of over 600 publications and is one of the world's most cited diabetes researchers.
{{cite news}}
: CS1 maint: url-status (link){{cite news}}
: CS1 maint: url-status (link){{cite news}}
: CS1 maint: url-status (link){{cite news}}
: CS1 maint: url-status (link){{cite web}}
: CS1 maint: url-status (link){{cite news}}
: CS1 maint: url-status (link)